Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
The House passed a massive, roughly $2 trillion infrastructure package that will give Medicare the power to narrowly negotiate prices on certain prescription drugs and close the Medicaid coverage gap. The package, called the Build Back Better Act, advanced out of the House late Thursday by a vote of 220 to 213. It now heads to ...
Providers could face a 40% cut on average to their Medicare Part B drug reimbursements under legislation that gives Medicare the power to negotiate a small amount of drug prices in Parts B and D, a new analysis finds. The analysis, released Thursday by consulting firm Avalere, examines the effect of a drug pricing negotiation ...
Democrats are close to making good on long-held promises to lower prescription drug costs and make health care more affordable. The rub? Voters won’t feel much of it until after the 2022 elections. The party is increasingly banking its midterm prospects on passage of the president’s domestic agenda in the coming weeks, convinced that it ...
President Joe Biden signed into law Monday a roughly $1 trillion infrastructure bill that pauses a controversial rebate rule from going into effect. The law aims to use funding from the cuts and other sources to make major investments in roads, bridges and other transportation items. The massive legislation also includes provisions aimed at increasing ...
The Centers for Medicare and Medicaid Services has increased Medicare Part B premiums, deductibles and coinsurance for next year in what will be a significant hike.
Switching seniors to Medicare Advantage plans has cost taxpayers tens of billions of dollars more than keeping them in original Medicare, a cost that has exploded since 2018 and is likely to rise even higher, new research has found. Richard Kronick, a former federal health policy researcher and a professor at the University of California-San ...
Medicare enrollees who take expensive medicines could save thousands of dollars a year under the Democrats’ sweeping social agenda bill, but those dividends won’t come overnight. Instead, they’ll build gradually over the decade. Unveiled late last week, the bill’s Medicare prescription drug compromise barely survived a pharmaceutical industry lobbying blitz. Experts who’ve analyzed the complex ...
Democrats on Tuesday announced an agreement on drug pricing reform, coming out in favor of allowing Medicare Part D to negotiate directly with pharmaceutical companies for the first time since its creation, a move the drug industry has fought for nearly two decades.
The pharmaceutical industry has strongly resisted some of the proposals presented in the years-long drug pricing brouhaha, and the final result is "not a bad outcome" for drugmakers, one team of analysts recently stated.
Nearly 100 million U.S. workers will be required to get the COVID vaccine by Jan. 4, with some workers allowed to test weekly instead, under sweeping federal rules released Thursday by the Biden administration that identifies COVID-19 as an occupational hazard. The regulations are aimed at health care workers and businesses with 100 or more ...